Global Expansion As ARG has become part of Evestia Clinical Group, you can market a globally distributed CRO with an established European foothold (Munich) and North American operations, appealing to sponsors needing cross-border trial execution and streamlined regulatory support.

Therapeutic Focus The focus on oncology, immunology, and neurology, combined with individualized trial design and advanced analytic capabilities, positions this CRO to win programs involving complex patient stratification and adaptive designs.

Full Service Leader From planning to commercialization, ARG offers end-to-end services plus drug and device strategic consulting and trial management, enabling sponsors to consolidate vendors and accelerate timelines.

Data and Analytics Promote its data and analytics capabilities to optimize trial design, monitoring, and regulatory readiness, addressing sponsor demands for evidence-based decisions and efficiency gains.

Partnership and Scale Recent leadership hires, strategic collaborations, and the Evestia integration create co-development and alliance opportunities with mid-to-large pharma seeking scalable trial execution and expanded market access.